PVI
Pura Vida Investments Portfolio holdings
AUM
$16.6M
This Quarter Return
+10.22%
1 Year Return
-3.82%
3 Year Return
-0.02%
5 Year Return
+29.84%
10 Year Return
+256.58%
AUM
$186M
AUM Growth
+$186M
(+73%)
Cap. Flow
+$65.9M
Cap. Flow
% of AUM
35.35%
Top 10 Holdings %
Top 10 Hldgs %
42.54%
Holding
123
New
33
Increased
21
Reduced
7
Closed
24
Top Buys
| 1 |
Boston Scientific
BSX
|
$8.78M |
| 2 |
Amgen
AMGN
|
$6.3M |
| 3 |
Azenta
AZTA
|
$5.7M |
| 4 |
Centene
CNC
|
$5.49M |
| 5 |
Orthofix Medical
OFIX
|
$5.26M |
Top Sells
| 1 |
ProQR Therapeutics
PRQR
|
$4.15M |
| 2 |
SIEN
Sientra, Inc.
SIEN
|
$3.59M |
| 3 |
Hologic
HOLX
|
$3.48M |
| 4 |
ATHN
Athenahealth, Inc.
ATHN
|
$3.34M |
| 5 |
AGN
Allergan plc
AGN
|
$3.33M |
Sector Composition
| 1 | Healthcare | 90.55% |
| 2 | Industrials | 1.5% |
| 3 | Technology | 0.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NVTR
26
DELISTED
Nuvectra Corporation Common Stock
NVTR
| $2.52M | 0.53% |
114,616
+49,616
| +76% | +$1.09M |
|
|
XENT
27
DELISTED
Intersect ENT, Inc
XENT
| $2.4M | 0.51% |
83,527
+11,027
| +15% | +$317K |
|
28
AtriCure
ATRC
$1.72B
| $2.37M | 0.5% |
+67,670
| New | +$2.37M |
|
|
RCM
29
DELISTED
R1 RCM Inc. Common Stock
RCM
| $2.31M | 0.49% |
+227,109
| New | +$2.31M |
|
|
ZGNX
30
DELISTED
Zogenix, Inc.
ZGNX
| $2.22M | 0.47% |
44,718
-550
| -1% | -$27.3K |
|
|
ALXN
31
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $2.1M | 0.44% |
15,124
+5,124
| +51% | +$712K |
|
|
TSRO
32
DELISTED
TESARO, Inc.
TSRO
| $1.98M | 0.42% |
+50,747
| New | +$1.98M |
|
|
VCRA
33
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $1.85M | 0.39% |
+50,622
| New | +$1.85M |
|
34
Natera
NTRA
$22.8B
| $1.7M | 0.36% |
+70,871
| New | +$1.7M |
|
35
Standard BioTools
LAB
$477M
| $1.69M | 0.35% |
+225,000
| New | +$1.69M |
|
36
Pacific Biosciences
PACB
$381M
| $1.64M | 0.35% |
+303,734
| New | +$1.64M |
|
|
IVC
37
DELISTED
Invacare Corporation
IVC
| $1.46M | 0.31% |
100,000
-22,735
| -19% | -$331K |
|
38
Arvinas
ARVN
$577M
| $1.27M | 0.27% |
+75,000
| New | +$1.27M |
|
|
BSTC
39
DELISTED
BioSpecifics Technologies Corp.
BSTC
| $1.18M | 0.25% |
+20,160
| New | +$1.18M |
|
|
40
ProQR Therapeutics
PRQR
$255M
| $1.1M | 0.23% |
56,803
-214,356
| -79% | -$4.15M |
|
|
GRTS
41
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $1.07M | 0.22% |
+75,000
| New | +$1.07M |
|
|
CLLS
42
Cellectis
CLLS
$262M
| $1M | 0.21% |
35,437
+437
| +1% | +$12.3K |
|
43
Rigel Pharmaceuticals
RIGL
$693M
| $971K | 0.2% |
302,489
-247,511
| -45% | -$795K |
|
|
OBSV
44
DELISTED
ObsEva SA Ordinary Shares
OBSV
| $913K | 0.19% |
50,622
-39,378
| -44% | -$710K |
|
45
Cartesian Therapeutics
RNAC
$266M
| $905K | 0.19% |
+58,205
| New | +$905K |
|
|
SPPI
46
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $840K | 0.18% |
+50,000
| New | +$840K |
|
47
Syndax Pharmaceuticals
SNDX
$1.37B
| $808K | 0.17% |
+100,000
| New | +$808K |
|
48
Madrigal Pharmaceuticals
MDGL
$9.54B
| $793K | 0.17% |
3,702
-9,398
| -72% | -$2.01M |
|
|
OTIC
49
DELISTED
Otonomy, Inc.
OTIC
| $791K | 0.17% |
287,657
+204,863
| +247% | +$563K |
|
50
BioCryst Pharmaceuticals
BCRX
$1.7B
| $773K | 0.16% |
+101,245
| New | +$773K |
|